Menopausal hormone therapy and the female brain: Leveraging neuroimaging and prescription registry data from the UK Biobank cohort
The authors received funding from the Research Council of Norway (LTW: 223273, 249795, 273345, 298646, 300768), the South-Eastern Norway Regional Health Authority (CB: 2023037, 2022103; LTW: 2018076, 2019101), the European Research Council under the European Union's Horizon 2020 research and innovation program (LTW: 802998), the Swiss National Science Foundation (AMGdL: PZ00P3_193658), the Canadian Institutes for Health Research (LAMG: PJT-173554), the Treliving Family Chair in Women's Mental Health at the Centre for Addiction and Mental Health (LAMG), womenmind at the Centre for Addiction and Mental Health (LAMG, BHL), the Ann S. Bowers Women's Brain Health Initiative (EGJ), and the National Institutes of Health (EGJ: AG063843).
Authors
- Lars Tjelta Westlye (ORCID: https://orcid.org/0000-0001-8644-956X)
- Bonnie H. Lee (ORCID: https://orcid.org/0000-0002-7661-9243)
- Cláudia Barth (ORCID: https://orcid.org/0000-0001-6544-0945)
- Emily Goard Jacobs (ORCID: https://orcid.org/0000-0003-0001-5096)
- Liisa A.M. Galea (ORCID: https://orcid.org/0000-0003-2874-9972)
- Ann‐Marie G. de Lange (ORCID: https://orcid.org/0000-0002-5150-6656)
Institutions
- Oslo University Hospital (NO)
- Centre for Addiction and Mental Health (CA)
- University of California, Santa Barbara (US)
- University of Oslo (NO)
- University of Toronto (CA)
- University of Oxford (GB)
- Diakonhjemmet Hospital (NO)
- University of Lausanne (CH)
Publication Details
- Journal
- eLife
- Published
- 2024-10-08
- DOI
- https://doi.org/10.7554/elife.99538
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science Foundation
- European Commission
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Universitetet i Oslo
- Norges Forskningsråd
- National Institutes of Health
- Helse Sør-Øst RHF